Irene Perlich - Jan 16, 2024 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC (NGM)

Role
PRINCIPAL ACCOUNTING OFFICER
Signature
/s/ Valerie Pierce, Attorney-in-Fact
Stock symbol
NGM
Transactions as of
Jan 16, 2024
Transactions value $
-$1,374
Form type
4
Date filed
1/18/2024, 06:02 PM
Previous filing
Nov 8, 2023
Next filing
Apr 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGM Common Stock Tax liability -$1.37K -1.03K -10.25% $1.34 8.98K Jan 16, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to satisfy the tax obligation realized in connection with the vesting of restricted stock units previously reported in Table 1.